Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)
7.62
+0.04 (0.53%)
Jul 17, 2025, 2:45 PM CST
SHE:002693 Revenue
Hainan Shuangcheng Pharmaceuticals had revenue of 36.68M CNY in the quarter ending March 31, 2025, a decrease of -14.23%. This brings the company's revenue in the last twelve months to 168.12M, down -14.75% year-over-year. In the year 2024, Hainan Shuangcheng Pharmaceuticals had annual revenue of 174.21M, down -26.16%.
Revenue (ttm)
168.12M
Revenue Growth
-14.75%
P/S Ratio
18.77
Revenue / Employee
277.88K
Employees
605
Market Cap
3.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 174.21M | -61.72M | -26.16% |
Dec 31, 2023 | 235.93M | -38.82M | -14.13% |
Jan 1, 2023 | 274.75M | -45.54M | -14.22% |
Jan 1, 2022 | 320.29M | 50.85M | 18.87% |
Dec 31, 2020 | 269.44M | -77.21M | -22.27% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |